To Determine the Safety, Tolerability, Pharmacokinetics and Effect on Pain of a Single Intra-articular Administration of Canakinumab in Patients With Osteoarthritis in the Knee

NCT01160822 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

BIOLOGICAL: Canakinumab
DRUG: Placebo to canakinumab
DRUG: Naproxen
DRUG: Placebo to Naproxen

Sponsor

Novartis Pharmaceuticals